THE ORIGIN OF RHEUMATOID ARTHRITIS IN ELDERLY PATIENTS
Article Sidebar
Main Article Content
Abstract
Abstract: Currently, the genetic mechanisms of rheumatoid arthritis (RA) have been studied more widely; other mechanisms, for example, pathological changes in the elderly that occur in the pathogenesis and progression of the disease remain out of sight. Timely diagnosis of rheumatoid arthritis in older adults allows timely adjustments to be made in treatment.
Article Details
References
Balabanova R.M., Kaptaeva A.K. Features of the clinical picture and treatment of rheumatoid arthritis in old age. Consilium Medicum. 2006; (12):12-82.
Bochkova AG. Rheumatoid arthritis with onset in old age: course and therapy. Clinical gerontology. 2002; 8(3):45-50.
Elamscheva I.Zh. Medical and occupational examination of patients with rheumatoid arthritis. Materials of the scientific and practical conference. Tashkent, 1990. - pp. 40-45.
Eliseev M.S., Zhelyabina O.V., Chikina M.N. et al. Effect of therapy on subclinical atherosclerosis of the carotid arteries in patients with calcium pyrophosphate crystal deposition disease and osteoarthritis (pilot study). //Scientific and practical rheumatology journal – 2021. – Volume: 59 – No. 6. –P.708-714.
Satybaldyev A.M. Rheumatoid arthritis in the elderly. Consilium Medicum.2007;9(12):85-92.
Haye-Salinas M.J., Bertoli A.M., Lema L., Saucedo C., Rosa J., Quintana R. Et al. Prevalence of dyslipidemia and elevated cardiovascular risk in patients with rheumatoid arthritis. //Medicina (B Aires) 2013; 73(1):26–30. [PubMed] [Google Scholar].
Curtis J.R., John A., Baser O. Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy. //Arthritis Care Res. 2012; 64(9):1282–1291. doi:10.1002/acr.21693. [PMC free article] [PubMed] [Google Scholar].
Leung B.P., Sattar N., Crilly A. et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. //J Immunol 2003; 170: 1524–1530.
McCarey D.W., McInnes I.B., Madhok R. et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double blind, randomized placebo-controlled trial. Lancet 2004; 363:2015–2021.